Skip to content

The historical opposition to psychedelic research and implications for credibility in psychiatry.

Elena Koning, Elvina M Chu, Elisa Brietzke

CNS Spectrums November 21, 2024 DOI: 10.1017/S1092852924002141 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Perspective article Peer reviewed
Keywords Drug policy Psychedelics Psychotherapy
Citations 5
Key points Argues that historical opposition to psychedelic research, including counterculture associations and scientific criticisms, has implications for the field's credibility and that learning from this history can inform current clinical research efforts.

Abstract

Psychedelics are a group of psychoactive substances that alter consciousness and produce marked shifts in sensory perception, cognition, and mood. Although psychedelics have been used by indigenous communities for centuries, they have only recently been investigated as an adjunctive therapeutic tool in psychotherapy. Since the early twentieth century, psychedelic-assisted psychotherapy has been explored for the treatment of several neuropsychiatric conditions characterized by rigid thought patterns and treatment resistance. However, this rapidly emerging field of neuroscience has evolved alongside opposition in several areas, including the affiliation with mid-twentieth century counterculture movements, media sensationalization, legislative restriction, and scientific criticisms such as "breaking the blind" and "excessive enthusiasm." This perspective article explores the historical opposition to psychedelic research and the implications for the credibility of the field. In the midst of psychedelic drug policy reform, drawing lessons from historical events will contribute to clinical research efforts in psychiatry.